2 unknown, 1 completed. 2 Phase 2, 1 Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Unknown 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 4 | 1 | Unknown 1 |
Follow Angioimmunoblastic T Cell Lymphoma: new trials by email Literature Review of Angioimmunoblastic T Cell Lymphoma trials Research Report on Angioimmunoblastic T Cell Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CEOP/IVE/GDP Compared With CEOP as the First-line Therapy for Newly Diagnosed Adult Patients With PTCL CEOP/IVE/GDP chemotherapy regimen, CEOP chemotherapy regimen for 6 cycles - Peripheral T-Cell Lymphoma, Not Otherwise Specified, Angioimmunoblastic T Cell Lymphoma | Phase 2 | Unknown | Shandong Provincial Hospital | 106 | 2015-09-01 | 2020-03-10 |
| CTOP/ITE/MTX Compared With CHOP as the First-line Therapy for Newly Diagnosed Young Patients With T Cell Lymphoma Cyclophosphamide 750mg/m2, Vincristine 1.4mg/m2, Doxorubicin 50mg/m2 - ALK-negative Anaplastic Large Cell Lymphoma, Peripherial T Cell Lymphoma,Not Otherwise Specified | Phase 4 | Unknown | Ruijin Hospital | 200 | 2012-09-01 | 2017-11-14 |
| RAD001 Combined With CHOP in Newly Diagnosed Peripheral T-cell Lymphomas RAD001 (Everolimus) - Peripheral T Cell Lymphoma Unspecified, Anaplastic Large Cell Lymphoma, ALK-negative | Phase 1 / Phase 2 | Completed | Samsung Medical Center | 46 | 2010-07-01 | 2015-03-03 |
Immunoblastic Lymphadenopathy (3) · Enteropathy-Associated T-Cell Lymphoma (2) · Lymphoma, T-Cell (2) · Subcutaneous panniculitis-like T-cell lymphoma (2) · Lymphoma, Large-Cell, Anaplastic (1) · Lymphoma, T-Cell, Cutaneous (1)
Hemic and Lymphatic Diseases (3) · Immune System Diseases (3) · Immunoproliferative Disorders (3) · Lymphadenopathy (3) · Lymphatic Diseases (3) · Lymphoma (3) · Lymphoma, Non-Hodgkin (3) · Lymphoproliferative Disorders (3) · Neoplasms (3) · Neoplasms by Histologic Type (3) · Lymphoma, T-Cell (1)
Cyclophosphamide (2) · Doxorubicin (2) · Vincristine (2) · Etoposide (1) · Everolimus (1) · Ifosfamide (1) · Methotrexate (1) · Prednisolone (1) · Prednisone (1) · etoposide phosphate (1) · pirarubicin (1) · prednylidene (1)
Ruijin Hospital (1) · Samsung Medical Center (1) · Shandong Provincial Hospital (1)
China (2) · South Korea (1)
Won Seog Kim, MD, PhD (1) · Xin Wang, PhD (1)